These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3324302)

  • 41. [Possibility of evaluating the degree of dissemination of malignant tumors of the bladder using ultrasonic tomography].
    Bal'ter SA; Matveev BP; Shipilov VI; Toktomushev AT; Mironova GT
    Vopr Onkol; 1986; 32(4):46-52. PubMed ID: 3518238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Histopathologic characteristics and clinical behavior of superficial bladder tumors].
    Kolozsy Z; Samodai L; Mohácsi L; Dauda G; Endresz KF
    Orv Hetil; 1990 Feb; 131(6):283-4, 287-9. PubMed ID: 2406685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Systematic histologic urinary bladder mapping in primary urinary bladder cancers].
    Theuring F; Theuring U
    Pathologe; 1990 May; 11(3):148-53. PubMed ID: 2374761
    [No Abstract]   [Full Text] [Related]  

  • 44. [Ultrasonographic assessment of bladder tumors: clinical staging].
    Niijima T
    Gan No Rinsho; 1983 Aug; 29(10):1175-80. PubMed ID: 6632204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On surgical treatment of so-called benign bladder tumors].
    Mebel M; Wilke H
    Z Urol Nephrol; 1966 Sep; 59(9):679-84. PubMed ID: 5997448
    [No Abstract]   [Full Text] [Related]  

  • 46. [Preoperative balloon occluded arterial infusion chemotherapy for locally invasive bladder cancer--accurate staging for bladder preservation].
    Hayashi N; Arima K; Kawamura J; Tochigi H
    Hinyokika Kiyo; 1999 Feb; 45(2):139-43. PubMed ID: 10212789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravesical ethoglucid (Epodyl) for treatment of noninvasive bladder cancer (stage Ta).
    Larson A; Fritjofsson A
    Ups J Med Sci; 1985; 90(2):127-32. PubMed ID: 3909592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of stage Ta,T1 and Tis bladder tumors using Calmette-Guérin bacillus vaccine].
    Bretheau D; Lechevallier E; Rossi D; Albert P; de Fromont M; Coulange C
    Prog Urol; 1993; 3(4):608-17. PubMed ID: 8401621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ta and T1 bladder cancer: location, recurrence and progression.
    Heney NM; Nocks BN; Daly JJ; Prout GR; Newall JB; Griffin PP; Perrone TL; Szyfelbein WA
    Br J Urol; 1982 Apr; 54(2):152-7. PubMed ID: 7082932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mitoxantrone chemoprophylaxis for multirecurrent multifocal superficial bladder tumours: results of a phase 2 controlled study].
    Bassi PF; Spinadin R; Carando R; Dal Moro F; Abatangelo G; Piazza N; Tavolini IM
    Arch Ital Urol Androl; 2003 Dec; 75(4):202-4. PubMed ID: 15005494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prognosis of superficial urothelial tumors of the bladder. Evaluation possibilities using the erythrocyte adherence test (SRCA test)].
    Krüger R; Reuter F; Deilmann W
    Pathologe; 1982 Sep; 3(5):266-71. PubMed ID: 7145864
    [No Abstract]   [Full Text] [Related]  

  • 52. Value of random mucosal biopsies in the management of superficial bladder cancer.
    Mufti GR; Singh M
    Eur Urol; 1992; 22(4):288-93. PubMed ID: 1490505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Transabdominal and transurethral scanning in the diagnosis of the bladder cancer stage].
    Stepanov VN; Perel'man VM; Abdukhakimov AF
    Urol Nefrol (Mosk); 1991; (2):33-7. PubMed ID: 2063502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conservative management of muscle-infiltrating bladder cancer: prospective experience.
    Herr HW
    J Urol; 1987 Nov; 138(5):1162-3. PubMed ID: 3669160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy and follow-up of bladder cancer].
    Meyer D; Schmid HP; Engeler DS
    Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Course of superficial carcinoma of bladder (Ta-T1). Apropos of 171 cases].
    Novak R
    J Urol (Paris); 1987; 93(1):21-4. PubMed ID: 3559256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The value of a second transurethral resection in evaluating patients with bladder tumours.
    Miladi M; Peyromaure M; Zerbib M; Saïghi D; Debré B
    Eur Urol; 2003 Mar; 43(3):241-5. PubMed ID: 12600426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
    Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
    BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Value of imaging procedures in the diagnosis and staging of bladder tumors].
    Nicolas V; Harder T; Steudel A; Krahe T; Schindler G; van Ahlen H; Jaeger N
    Rofo; 1988 Mar; 148(3):234-9. PubMed ID: 2832883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
    Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.